Wix.com is a platform that gives you the freedom to create, design, manage and develop your web presence exactly the way you want.
Location: Switzerland, Basel-City, Basel
Employees: 1-10
Total raised: $1.13M
Founded date: 2022
Investors 2
| Date | Name | Website |
| - | Venture Ki... | venturekic... |
| - | VentureLab | venturelab... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.02.2024 | - | $1.13M | - |
Mentions in press and media 12
| Date | Title | Description |
| 08.04.2025 | University Hospital Zurich's Health Innovation Hub expands portfolio | The Health Innovation Hub (HIH) is the startup support arm of the Innovation & Startup Center (ISC) of the USZ, which was founded by the USZ in 2018. The aim of the ISC is to promote entrepreneurship and innovation in healthcare at and... |
| 31.03.2025 | BioEntrepreneurship: Catalyzing innovation from Lab to market | Swiss universities are innovation hubs, where novel ideas are born with the potential to address critical global challenges. Yet, without the right support, many of these promising concepts remain confined to the lab. The Institute of Rege... |
| 29.02.2024 | FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund | FimmCyte is a spin-off company from the University of Zürich and the University Hospital Zürich, the Lab of Prof. Brigitte Leener, and was founded in 2022 by Valentina Vongrad and Mohaned Shilaih. The pre-clinical stage biotechnology compa... |
| 29.02.2024 | FimmCyte secures 1 million CHF investment for Non-Hormonal Endometriosis treatment | FimmCyte secures 1 million CHF investment for Non-Hormonal Endometriosis treatment 29.02.2024 16:00, Rita Longobardi linkedIn facebook twitter instagram youtube --> FimmCyte, an innovative biotech company dedicated to women's health, has... |
| 29.02.2024 | FimmCyte secures 1 million CHF investment for Non-Hormonal Endometriosis treatment | FimmCyte, a spin-off from the University of Zürich and the University Hospital Zürich, was established in 2022 by Valentina Vongrad and Mohaned Shilaih. This pre-clinical stage biotech firm, stemming from the Lab of Prof. Brigitte Leener, f... |
| 28.02.2024 | FimmCyte announces an investment of 1 million CHF as a convertible loan from the UZH Life Sciences Fund | FimmCyte Logo FimmCyte, a pioneering women's health biotech, announces an investment of 1 million CHF as a convertible loan from the UZH Life Sciences Fund BASEL, SWITZERLAND, February 28, 2024 /EINPresswire.com/ -- FimmCyte, a pioneering w... |
| 21.07.2022 | Ten Biotech startups brace for Boston | |
| 13.07.2022 | FimmCyte obtains CHF 150’000 to tackle Endometriosis | |
| 18.05.2022 | MassChallenge Switzerland announces 2022 cohort | |
| 31.03.2022 | A second cohort joins Tech4Eva accelerator |
Show more